CSF S100B is elevated during acute attacks of NMOSD compared to MS and other neurologic diseases, is significantly higher in AQP4-IgG-positive NMOSD compared to seronegative disease, and correlates with Expanded Disability Status Scale (EDSS) during both attack and remission (28). Here, AQP4 is linked to myeloid sarcoma.